Clinical Trial

Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR)

Study acronym: SAPHIR
Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to phenotype hearing in patients with early stage of neurodegenerative disorders to explore the prevalence of various hearing disorders in comparison to a control population. Specific focus is made on patients with speech-in-noise intelligibiltiy deficit despite normal tonal audiograms referred to as hidden hearing loss, with potential identification of associated biomarkers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-16.
Trial Details
NCT Number NCT07083089
Lead Sponsor Cilcare SAS
Conditions Mild Cognitive Impairment (MCI) Amnestic, Parkinson Disease (PD), Healthy Participants
Enrollment 309 participants
Start Date 2025-03-24
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-09